HHS To Help Companies Develop COVID-19 Vaccines
The Department of Health and Human Services outlined support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.
by Sydney Lupkin
Mar 31, 2020
2 minutes
The Department of Health and Human Services outlined how it will support Moderna and Johnson & Johnson as they develop vaccines against the novel coronavirus that's sickened more than 800,000 people worldwide as of Tuesday afternoon.
HHS's Biomedical Advanced Research and Development Authority, that it will help speed up clinical trials for both companies' experimental vaccines, and support Janssen Pharmaceuticals, a unit of Johnson & Johnson, in making up to 300 million doses annually in the U.S..
You’re reading a preview, subscribe to read more.
Start your free 30 days